Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Hormones and the Endocrine System > Eloralintide for Sale > Eloralintide API from Nanjing hanxin/Manufacturer directly/ FDA audited factory
Eloralintide API from Nanjing hanxin/Manufacturer directly/ FDA audited factory buy - large image1
Eloralintide API from Nanjing hanxin/Manufacturer directly/ FDA audited factory buy - image1

Eloralintide API from Nanjing hanxin/Manufacturer directly/ FDA audited factory

84 Inquiries

Unit Price: Get Latest Price
CAS No.:

2883634-40-8

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Any chinese airport

Brand:

Hanxin

Packaging:

100g/bag, 500g/bag

Price valid (until):

2026-05-02

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

Semaglutide,Tirzepatide,Retatrutide,Liraglutide,Semoreln Acetate,lpamoreln

  • Product Details

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Eloralintide, GLP-1
    (Please note that the Eloralintide we supply is API not lyophilized powder)

    Whatsapp 0086-13859902876


    Purity: NLT 99%
    Appearance: White to off-white powder
    Storage Conditions: -20°C±5°C (dry, protected from light)
    Our core compentency:
    1. FDA audited site. Prodution strictly follow GMP
    2. USDMF
    3. FDA green list member for GLP-1 product 
    Indications
    Type 2 diabetes mellitus (T2DM)
    Obesity
    We are looking for wholesale, agent and pharmaceutical company to explore business. 
    *************************************************
    Contact Person:Julie Zheng
    Tel: +86 13859902876
    Whatsapp 0086-13859902876
    E-mail:julie@hanxinpharm.com

    Items Specifications






    ECHEMI Editorial Reference

    Eloralintide (CAS No. 2883634-40-8) is a long-acting amylin analog and peptide-based pharmaceutical ingredient. Its modified peptide structure features a methylene thioacetal bridge and a C20 fatty diacid side chain, contributing to its distinctive molecular and physicochemical properties. As a peptide pharmaceutical raw material, Eloralintide is suitable for API research, analytical studies, and pharmaceutical development.

    Basic Info
    Product Name:

    Eloralintide

    Other Name:

    Eloralintide;AMY1176;LY3841136;Eloralintide,LY3841136

    CAS No.:

    2883634-40-8

    Molecular Weight:

    0

    EC Number:

    262-076-3

    Color/Form:

    White to off-white

    Research
    Class:

    Amylin receptor (AMYR) agonist (peptide, long-acting)

    Status:

    Investigational — Phase 1/2 (T2DM and obesity)

    Mechanism:

    Eloralintide is an amylin receptor agonist developed by Eli Lilly for type 2 diabetes and obesity. It activates the amylin receptor (AMYR), reducing food intake, delaying gastric emptying, and promoting satiety. It is structurally distinct from cagrilintide (Novo Nordisk). Being explored as monotherapy and in combination with GLP-1R agonists.

    Activity note:

    Limited public data. Eloralintide is in early clinical development; specific EC50 values have not been publicly disclosed.

    Source:

    MCE: Eloralintide (CAS 2883634-40-8); AbMole product data sheet.

    References
    PubChem:

    PubChem

    Disclaimer:

    Eloralintide is NOT FDA-approved or EMA-approved. It is in Phase 1/2 clinical development by Eli Lilly. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Semaglutide,Tirzepatide,Retatrutide,Liraglutide,Semoreln Acetate,lpamoreln

    Location:

    Building C5, No.9 Weidi Road, Xianlin street, Xixia district

    Total Employees:

    301-500

    Year of Establishment:

    2017

  • Inquiry History
    84 Inquiries
    Country Product Purchase Quantity Date Posted
    Philippines

    Elora

    5 MG Oct 27, 2026
    Germany

    Eloralintide, Lyophilised (Freeze-Dried) Peptides – High Purity / Low Endotoxin (LPS Removed)

    100  Oct 26, 2026
    United States

    Eloralintide (LY-3841136)

    1  Oct 24, 2026
    Netherlands

    Eloralintide

    10 MG Oct 22, 2026
    France

    eloralintide

    1 MT Oct 21, 2026
    South Korea

    Eloralintide

    1 G Oct 21, 2026
    United States

    Eloralintide

    10 PCS Oct 21, 2026
    United Kingdom

    Eloralintide

    100 PCS Oct 20, 2026
    United States

    Eloralintide

    20 MG Oct 19, 2026
    United States

    Eloralintide

    1 MT Oct 16, 2026
    United States

    Eloralintide

    10 MT Oct 10, 2026
    Germany

    Eloralintide

    1 PCS Oct 10, 2026
    United States

    eloralintide

    10 MG Oct 6, 2026
    United States

    Eloralintide

    10 MG Oct 5, 2026
    United Kingdom

    Eloralintide vials

    5 PCS Oct 4, 2026
    Australia

    ELORALINTIDE

    10 PCS Oct 2, 2026
    Brazil

    Eloralintide

    5 MT Oct 2, 2026
    Australia

    Eoralintide

    10 PCS Oct 1, 2026
    United Kingdom

    Eloralitide

    2 G Sep 27, 2026
    United Kingdom

    Eloralintide

    30 MG Sep 22, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.